Clinical investigations involving human subjects and drugs, biologics, devices or test articles are subject to review. In order to comply with federal regulations, the IRB will determine what types of applications and exemptions (when applicable) are required for the study. This document describes various types of studies and instructions for submission and compliance.

This policy outlines the requirements for formulating contracts with sponsors of proposed research.

This policy describes the process by which the IRB determines if risks are minimized for participants in a proposed project. Review process and relevant definitions are included in the document.

This policy requires the implenmentation of a quality assurance and quality improvement program to monitor compliance with federal regulations and improve the Human Research Protection Program processes

This policy describes the IRB's obligation to report certain determinations to UAB officials, regulatory and other federal regulatory agencies, and sponsors.

This policy outlines UAB's approach to determining whether use of commercially available cell lines is defined as human subjects research.

This policy details the process for reviewing and handling financial (or other) conflicts of interest surrounding the investigator of a proposed project.

This policy establishes UAB’s program for the protection of human subjects and describes the ethical standards and institutional commitments applicable to the conduct of human subjects research at UAB.

This policy requires owners/operators of chartered, leased, or loaned aircraft to provide evidence of aviation liability insurance and defines limits of liability defined by type and use of the aircraft.

This document details specific biosafety guidelines for UAB laboratories and facilities that use biological agents.